North America Restriction Endonucleases Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Choose Licence

 

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another. Scope of the Report: This report focuses on the Restriction Endonucleases in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers New England Biolabs Thermo Fisher Scientific Takara Bio Illumina Agilent Technologies Roche GE Healthcare Promega Corporation Qiagen Jena Biosciences Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Type I Type II Type III Type IV Others Market Segment by Applications, can be divided into Academic & Research Institutes Hospitals & Diagnostic Centers Biopharmaceutical Other There are 15 Chapters to deeply display the North America Restriction Endonucleases market. Chapter 1, to describe Restriction Endonucleases Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Restriction Endonucleases, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Restriction Endonucleases, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Restriction Endonucleases market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Restriction Endonucleases Research Findings and Conclusion, Appendix, methodology and data source

 

Table of Contents 1 Market Overview 1.1 Restriction Endonucleases Introduction 1.2 Market Analysis by Type 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.2.4 Type IV 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Academic & Research Institutes 1.3.2 Hospitals & Diagnostic Centers 1.3.3 Biopharmaceutical 1.3.4 Other 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Prospect (2012-2022) 1.4.3 Canada Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 New England Biolabs 2.1.1 Profile 2.1.2 Restriction Endonucleases Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 New England Biolabs News 2.2 Thermo Fisher Scientific 2.2.1 Profile 2.2.2 Restriction Endonucleases Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Thermo Fisher Scientific News 2.3 Takara Bio 2.3.1 Profile 2.3.2 Restriction Endonucleases Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Takara Bio News 2.4 Illumina 2.4.1 Profile 2.4.2 Restriction Endonucleases Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Illumina News 2.5 Agilent Technologies 2.5.1 Profile 2.5.2 Restriction Endonucleases Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview 2.5.5 Agilent Technologies News 2.6 Roche 2.6.1 Profile 2.6.2 Restriction Endonucleases Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.4 Business Overview 2.6.5 Roche News 2.7 GE Healthcare 2.7.1 Profile 2.7.2 Restriction Endonucleases Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7.4 Business Overview 2.7.5 GE Healthcare News 2.8 Promega Corporation 2.8.1 Profile 2.8.2 Restriction Endonucleases Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8.4 Business Overview 2.8.5 Promega Corporation News 2.9 Qiagen 2.9.1 Profile 2.9.2 Restriction Endonucleases Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9.4 Business Overview 2.9.5 Qiagen News 2.10 Jena Biosciences 2.10.1 Profile 2.10.2 Restriction Endonucleases Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10.4 Business Overview 2.10.5 Jena Biosciences News 3 North America Restriction Endonucleases Market Competition, by Manufacturer 3.1 North America Restriction Endonucleases Sales and Market Share by Manufacturer (2016-2017) 3.2 North America Restriction Endonucleases Revenue and Market Share by Manufacturer (2016-2017) 3.3 North America Restriction Endonucleases Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Restriction Endonucleases Manufacturer Market Share 3.4.2 Top 5 Restriction Endonucleases Manufacturer Market Share 3.5 Market Competition Trend 4 North America Restriction Endonucleases Market Analysis by Countries 4.1 North America Restriction Endonucleases Sales Market Share by Countries 4.2 North America Restriction Endonucleases Sales by Countries (2012-2017) 4.3 North America Restriction Endonucleases Revenue (Value) by Countries (2012-2017) 5 North America Market Segmentation Restriction Endonucleases by Type 5.1 North America Restriction Endonucleases Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 North America Restriction Endonucleases Sales and Market Share by Type (2012-2017) 5.1.2 North America Restriction Endonucleases Revenue and Market Share by Type (2012-2017) 5.2 Type I Sales Growth and Price 5.2.1 North America Type I Sales Growth (2012-2017) 5.2.2 North America Type I Price (2012-2017) 5.3 Type II Sales Growth and Price 5.3.1 North America Type II Sales Growth (2012-2017) 5.3.2 North America Type II Price (2012-2017) 5.4 Type III Sales Growth and Price 5.4.1 North America Type III Sales Growth (2012-2017) 5.4.2 North America Type III Price (2012-2017) 5.5 Type IV Sales Growth and Price 5.5.1 North America Type IV Sales Growth (2012-2017) 5.5.2 North America Type IV Price (2012-2017) 5.6 Others Sales Growth and Price 5.6.1 North America Others Sales Growth (2012-2017) 5.6.2 North America Others Price (2012-2017) 6 North America Market Segmentation Restriction Endonucleases by Application 6.1 North America Restriction Endonucleases Sales Market Share by Application (2012-2017) 6.2 Academic & Research Institutes Sales Growth (2012-2017) 6.3 Hospitals & Diagnostic Centers Sales Growth (2012-2017) 6.4 Biopharmaceutical Sales Growth (2012-2017) 6.5 Other Sales Growth (2012-2017) 7 United States Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers 7.1 United States Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017) 7.2 United States Restriction Endonucleases Sales and Market Share by Type 7.3 United States Restriction Endonucleases Sales by Application (2012-2017) 7.4 United States Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer 7.4.1 United States Restriction Endonucleases Sales and Market Share by Manufacturer 7.4.2 United States Restriction Endonucleases Revenue and Market Share by Manufacturer 7.5 United States Restriction Endonucleases Export and Import (2012-2017) 8 Canada Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers 8.1 Canada Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017) 8.2 Canada Restriction Endonucleases Sales and Market Share by Type 8.3 Canada Restriction Endonucleases Sales by Application (2012-2017) 8.4 Canada Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer 8.4.1 Canada Restriction Endonucleases Sales and Market Share by Manufacturer 8.4.2 Canada Restriction Endonucleases Revenue and Market Share by Manufacturer 8.5 Canada Restriction Endonucleases Export and Import (2012-2017) 9 Mexico Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers 9.1 Mexico Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017) 9.2 Mexico Restriction Endonucleases Sales and Market Share by Type 9.3 Mexico Restriction Endonucleases Sales by Application (2012-2017) 9.4 Mexico Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer 9.4.1 Mexico Restriction Endonucleases Sales and Market Share by Manufacturer 9.4.2 Mexico Restriction Endonucleases Revenue and Market Share by Manufacturer 9.5 Mexico Restriction Endonucleases Export and Import (2012-2017) 10 Restriction Endonucleases Market Forecast (2017-2022) 10.1 North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022) 10.2 Restriction Endonucleases Market Forecast by Countries (2017-2022) 10.2.1 United States Restriction Endonucleases Forecast (2017-2022) 10.2.2 Canada Restriction Endonucleases Forecast (2017-2022) 10.2.3 Mexico Restriction Endonucleases Forecast (2017-2022) 10.3 Restriction Endonucleases Market Forecast by Type (2017-2022) 10.4 Restriction Endonucleases Market Forecast by Application (2017-2022) 11 Restriction Endonucleases Manufacturing Cost Analysis 11.1 Restriction Endonucleases Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Restriction Endonucleases 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Restriction Endonucleases Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016 12.4 Downstream Buyers 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Restriction Endonucleases Picture Table Product Specifications of Restriction Endonucleases Figure North America Sales Market Share of Restriction Endonucleases by Types in 2016 Table Types of Restriction Endonucleases Figure Type I Picture Table Major Manufacturers of Type I Figure Type II Picture Table Major Manufacturers of Type II Figure Type III Picture Table Major Manufacturers of Type III Figure Type IV Picture Table Major Manufacturers of Type IV Figure Others Picture Table Major Manufacturers of Others Table North America Restriction Endonucleases Sales Market Share by Applications in 2016 Table Applications of Restriction Endonucleases Figure Academic & Research Institutes Picture Figure Hospitals & Diagnostic Centers Picture Figure Biopharmaceutical Picture Figure Other Picture Figure United States Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022) Figure Mexico Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022) Figure Canada Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022) Table New England Biolabs Basic Information, Manufacturing Base and Competitors Table New England Biolabs Restriction Endonucleases Type and Applications Table New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors Table Thermo Fisher Scientific Restriction Endonucleases Type and Applications Table Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takara Bio Basic Information, Manufacturing Base and Competitors Table Takara Bio Restriction Endonucleases Type and Applications Table Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Illumina Basic Information, Manufacturing Base and Competitors Table Illumina Restriction Endonucleases Type and Applications Table Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Agilent Technologies Basic Information, Manufacturing Base and Competitors Table Agilent Technologies Restriction Endonucleases Type and Applications Table Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Restriction Endonucleases Type and Applications Table Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GE Healthcare Basic Information, Manufacturing Base and Competitors Table GE Healthcare Restriction Endonucleases Type and Applications Table GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Promega Corporation Basic Information, Manufacturing Base and Competitors Table Promega Corporation Restriction Endonucleases Type and Applications Table Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Qiagen Basic Information, Manufacturing Base and Competitors Table Qiagen Restriction Endonucleases Type and Applications Table Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Jena Biosciences Basic Information, Manufacturing Base and Competitors Table Jena Biosciences Restriction Endonucleases Type and Applications Table Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table North America Restriction Endonucleases Sales by Manufacturer (2016-2017) Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2016 Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2017 Table North America Restriction Endonucleases Revenue by Manufacturer (2016-2017) Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2016 Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2017 Table North America Restriction Endonucleases Price by Manufacturers (2016-2017) Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2016 Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2017 Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2016 Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2017 Figure North America Restriction Endonucleases Sales and Growth (2012-2017) Table North America Restriction Endonucleases Sales by Countries (2012-2017) Table North America Restriction Endonucleases Sales Market Share by Countries (2012-2017) Figure North America 2012 Restriction Endonucleases Sales Market Share by Countries Figure North America 2016 Restriction Endonucleases Sales Market Share by Countries Figure North America Restriction Endonucleases Revenue and Growth (2012-2017) Table North America Restriction Endonucleases Revenue by Countries (2012-2017) Table North America Restriction Endonucleases Revenue Market Share by Countries (2012-2017) Table North America 2012 Restriction Endonucleases Revenue Market Share by Countries Table North America 2016 Restriction Endonucleases Revenue Market Share by Countries Table North America Restriction Endonucleases Sales by Type (2012-2017) Table North America Restriction Endonucleases Sales Share by Type (2012-2017) Table North America Restriction Endonucleases Revenue by Type (2012-2017) Table North America Restriction Endonucleases Revenue Share by Type (2012-2017) Figure North America Type I Sales Growth (2012-2017) Figure North America Type I Price (2012-2017) Figure North America Type II Sales Growth (2012-2017) Figure North America Type II Price (2012-2017) Figure North America Type III Sales Growth (2012-2017) Figure North America Type III Price (2012-2017) Figure North America Type IV Sales Growth (2012-2017) Figure North America Type IV Price (2012-2017) Figure North America Others Sales Growth (2012-2017) Figure North America Others Price (2012-2017) Table North America Restriction Endonucleases Sales by Application (2012-2017) Table North America Restriction Endonucleases Sales Share by Application (2012-2017) Figure North America Academic & Research Institutes Sales Growth (2012-2017) Figure North America Hospitals & Diagnostic Centers Sales Growth (2012-2017) Figure North America Biopharmaceutical Sales Growth (2012-2017) Figure North America Other Sales Growth (2012-2017) Figure United States Restriction Endonucleases Revenue and Growth (2012-2017) Figure United States Restriction Endonucleases Sales and Growth (2012-2017) Table United States Restriction Endonucleases Sales by Type (2012-2017) Table United States Restriction Endonucleases Sales Market Share by Type (2012-2017) Table United States Restriction Endonucleases Sales by Application (2012-2017) Table United States Restriction Endonucleases Sales Market Share by Application (2012-2017) Table United States Restriction Endonucleases Sales by Manufacturer (2016-2017) Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2016 Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2017 Table United States Restriction Endonucleases Revenue by Manufacturer (2016-2017) Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2016 Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2017 Table United States Restriction Endonucleases Export and Import (2012-2017) Figure Canada Restriction Endonucleases Revenue and Growth (2012-2017) Figure Canada Restriction Endonucleases Sales and Growth (2012-2017) Table Canada Restriction Endonucleases Sales by Type (2012-2017) Table Canada Restriction Endonucleases Sales Market Share by Type (2012-2017) Table Canada Restriction Endonucleases Sales by Application (2012-2017) Table Canada Restriction Endonucleases Sales Market Share by Application (2012-2017) Table Canada Restriction Endonucleases Sales by Manufacturer (2016-2017) Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2016 Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2017 Table Canada Restriction Endonucleases Revenue by Manufacturer (2016-2017) Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2016 Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2017 Table Canada Restriction Endonucleases Export and Import (2012-2017) Figure Mexico Restriction Endonucleases Revenue and Growth (2012-2017) Figure Mexico Restriction Endonucleases Sales and Growth (2012-2017) Table Mexico Restriction Endonucleases Sales by Type (2012-2017) Table Mexico Restriction Endonucleases Sales Market Share by Type (2012-2017) Table Mexico Restriction Endonucleases Sales by Application (2012-2017) Table Mexico Restriction Endonucleases Sales Market Share by Application (2012-2017) Table Mexico Restriction Endonucleases Sales by Manufacturer (2016-2017) Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2016 Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2017 Table Mexico Restriction Endonucleases Revenue by Manufacturer (2016-2017) Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2016 Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2017 Table Mexico Restriction Endonucleases Export and Import (2012-2017) Figure North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022) Table North America Restriction Endonucleases Sales Forecast by Countries (2017-2022) Table North America Restriction Endonucleases Market Share Forecast by Countries (2017-2022) Figure United States Restriction Endonucleases Sales Forecast (2017-2022) Figure Canada Restriction Endonucleases Sales Forecast (2017-2022) Figure Mexico Restriction Endonucleases Sales Forecast (2017-2022) Table North America Restriction Endonucleases Sales Forecast by Type (2017-2022) Table North America Restriction Endonucleases Market Share Forecast by Type (2017-2022) Table North America Restriction Endonucleases Sales Forecast by Application (2017-2022) Table North America Restriction Endonucleases Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Restriction Endonucleases Figure Manufacturing Process Analysis of Restriction Endonucleases Figure Restriction Endonucleases Industrial Chain Analysis Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016 Table Major Buyers of Restriction Endonucleases Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Other Reports by GlobalInfoResearch

EMEA (Europe, Middle East and Africa) Wireless Test Equipment Market 2017 Forecast to 2022

This report studies the Wireless Test Equipment market, from angles of players, regions, product types and end industries, to analyze the status and the future. Scope of the Report: This report focuses on the Wireless Test Equipment in EMEA mar...

EMEA (Europe, Middle East and Africa) Petroleum Needle Coke Market 2017 Forecast to 2022

Petroleum needle coke is a needle-shaped carbon material produced by heating raw petroleum coke (a solid carbon derived from cracking of heavy oil), and is mainly used as the aggregate of artificial graphite electrodes in electric arc furnaces for th...

EMEA (Europe, Middle East and Africa) Offshore AUV Market 2017 Forecast to 2022

Autonomous Operated Vehicles (AUV) is the unmanned underwater vehicles which are operated without direct human intervention. They are being designed to perform underwater survey missions required in commercial, scientific research, and defense sector...

EMEA (Europe, Middle East and Africa) Neurological Biomarkers Market 2017 Forecast to 2022

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measur...

EMEA (Europe, Middle East and Africa) Gift Cards Market 2017 Forecast to 2022

A gift card (also known as gift certificate in North America, or gift voucher or gift token in the UK) is a prepaid stored-value money card usually issued by a retailer or bank to be used as an alternative to cash for purchases within a particular st...

New Pharmaceuticals and Healthcare Reports